~Hidemasa’s appointment bolsters Aculys’ position as a leader in the field of CNS in Japan and Asia~ TOKYO, April 1, 2024 /PRNewswire/ — Aculys Pharma, Inc. (“Aculys”), a clinical-stage biopharmaceutical company focused on commercializing innovative treatments for neurological…



Leave a Reply

Your email address will not be published. Required fields are marked *